Imagion Biosystems Limited (IBX:ASX)

18.0¢

right-arrow Created with Sketch. -0.005 (-2.7%)
MCAP $189.9M
Last trade 14.38pm 26/02/2021 20mins delayed

Latest Announcements

25/02/2021 Price SensitivePSIBXImagion Biosystems Limited
25/02/2021IBXImagion Biosystems Limited
25/02/2021IBXImagion Biosystems Limited
25/02/2021 Price SensitivePSIBXImagion Biosystems Limited
751
MCap
19/02/2021IBXImagion Biosystems Limited
19/02/2021IBXImagion Biosystems Limited
10/02/2021IBXImagion Biosystems Limited
10/02/2021IBXImagion Biosystems Limited
458
MCap

Company Overview

Imagion Biosystems Limited is an Australia-based is engaged in the business of research and development of medical imaging technology through its wholly owned subsidiary, Imagion Biosystems Inc. The Company is focused on the research and development of the MagSense SPMR technology. The Company's technologies include MagSense technology and PrecisionMRX nanoparticles. MagSense technology differentiates benign from malignant tumors since the antibody-conjugated nanoparticles only bind to the targeted tumor cells. MagSense instrument uses sensitive magnetic field sensors to detect the remnant magnetic relaxation of the injected nanoparticles. MagSense nanoparticles are supplied as an injectable solution and formulated to provide delivery to specific types of cancer cells. PrecisionMRX nanoparticles are characterized superparamagnetic nanoparticles. The Company serves a range of applications, including detecting cancer, monitoring therapy and detecting other diseases.

IBX in the news

Search Previous Announcements